Skip to content
Home/Companies/Biotechnology/Minos Biosciences

Minos Biosciences

Biotechnology·France·Active·13yr hold
Entry
2013
Hold
13yr
Status
Active

Who owns Minos Biosciences?

Minos Biosciences is currently owned by Elaia Partners through Elaia Alpha Fund (2012 vintage), since 2013.

Hand-verified · updated 2026-04-21

Elaia Partners
Investor
Elaia Partners
Elaia Alpha Fund · 2012 · VC

Key facts

HQFrance
SectorBiotechnology

More from Elaia Alpha Fund

Other portfolio companies in the same fund.

Argosim
Exited 2019
DevToolsFrance· 2016
to
Mediego
Exited 2019
SoftwareFrance· 2016
to
C-Radar (DataPublica)
Exited 2017
Data & AnalyticsFrance· 2014
to
Cryptosense
Exited 2022
Data & AnalyticsFrance· 2014
to
Niland
Exited 2017
AI/MLFrance· 2013
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Minos Biosciences

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Minos Biosciences?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Minos Biosciences.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue